A detailed analysis of immune cells in Long COVID patients has revealed a previously unknown molecular signature linked to lingering symptoms. In Germany, Long COVID develops in up to about one in ten people after an infection with the SARS-CoV-2 virus. For some, the illness does not end when the virus clears. Instead, a mix […]
Source link